CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 77 filers reported holding CYTOSORBENTS CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $122,000 | -26.1% | 31,670 | -3.7% | 0.00% | 0.0% |
| Q3 2019 | $165,000 | -24.7% | 32,870 | -0.9% | 0.00% | -50.0% |
| Q2 2019 | $219,000 | +0.9% | 33,170 | +15.8% | 0.00% | 0.0% |
| Q1 2019 | $217,000 | -0.9% | 28,640 | +5.4% | 0.00% | 0.0% |
| Q4 2018 | $219,000 | -29.4% | 27,161 | +13.2% | 0.00% | -33.3% |
| Q3 2018 | $310,000 | +25.5% | 24,001 | +10.9% | 0.00% | 0.0% |
| Q2 2018 | $247,000 | +48.8% | 21,650 | -8.1% | 0.00% | +50.0% |
| Q1 2018 | $166,000 | +36.1% | 23,548 | +25.9% | 0.00% | 0.0% |
| Q4 2017 | $122,000 | +17.3% | 18,700 | +12.0% | 0.00% | 0.0% |
| Q3 2017 | $104,000 | -55.6% | 16,700 | -69.3% | 0.00% | -50.0% |
| Q2 2017 | $234,000 | -84.3% | 54,385 | -83.6% | 0.00% | -86.7% |
| Q1 2017 | $1,490,000 | -18.9% | 331,195 | -1.8% | 0.03% | -28.6% |
| Q4 2016 | $1,838,000 | -6.2% | 337,395 | +10.2% | 0.04% | -10.6% |
| Q3 2016 | $1,959,000 | +42.8% | 306,145 | +1.4% | 0.05% | +30.6% |
| Q2 2016 | $1,372,000 | – | 301,845 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |